Suggest
#1 in Business Subscribe Email Print

You are here: Home > Finance > Stocks Mutual Funds > Commodity Trading Blunders IV, PART 4 - My Early Days As A Novice Trader

Tags

  • started
  • their
  • developing
  • commodity futures
  • commodity futures

  • Links

  • Are all Voters Equal in the United Kingdom?
  • How Your Online Business Can Generate Loads Of Free Traffic From Articles
  • A Guide To Teachers
  • Suggest - Commodity Trading Blunders IV, PART 4 - My Early Days As A Novice Trader

    Speaking of sugar, I later took the plunge. My swing program said sugar was due for a big swing up. Trident normally tracked the standard 1-2-3 zigzag move and entered th
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    e “3” wave. I went long four sugar futures contracts on this signal. The trade started out fine but stalled and reversed down.

    Max suggested I sell four farth
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    r out futures contracts as a hedge. (That makes a lot sense, right?) He said this way I would be more apt to later remove the hedge. Otherwise, I might not get back in. Wh
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    atever. Of course, I put the hedge on at the exact low when I was the most scared. As sugar futures started to rally again, I removed the hedge and the race was on.

    Maybe
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    Max was right. Sugar futures contracts ran up to my Trident objective and I got out with a few grand profit. I got cocky and stupid and decided to reverse and go short fou
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    r contracts at the close on Friday. Trident was flat and I was doing a "drunken sailor" trade. I was so pumped up I gave two of my employees a share of the poten
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    ial profits. Monday came and sugar gapped up against me. In no time I gave back all my previous sugar profits. I got out and decided never to buck the trend again. Well, a
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    t least until I got greedy and stupid again. I told my two employees to forget about any losses and that was that.

    Max was making good futures commissions from me and I t
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    ink I was becoming one of his more active commodity traders. I liked that feeling. I even told some of the young women I met that I was a commodity futures trader. That we
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    nt nowhere. Back then, it was like saying I played poker or shot craps for a living. But, I couldn’t leave sugar alone. A few days after that loss, the market was st
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    ll moving up. It was Friday again. The futures market had moved up about 350 points that week. It was kissing 23 cents. I said the heck with Trident and told Max to buy on
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    futures contract at the market.

    After his “lightning fast” execution finally got back to me, I had paid about 50 points more than the last quote! I was stunn
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    ed. But then it kept going up into the close. It closed limit up and I was up a good $1000 on one contract. (The limits were expanded yet again) Monday came and it was lim
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    t up again. A few more limit up days and I got out with a nice $5,000 gain. Too bad I didn’t buy four contracts, but I was still feeling the pain of the last loser.
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen


    Those were some fun days trading futures. I still look back and realize my innocence was in many ways my strength. After all, it was a bull market in commodities and &ld
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    uo;drunken sailor” trades usually work out. But as the years passed, so did the bull, bear and chopping markets. I learned how the commodity futures markets could be
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    at you up. I replaced my intense aggressiveness and became conservative in a speculative arena. But that’s the way you need to be.

    It’s all about survival. Sm
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    ll positions that go far are a great way to trade. Ringing the cash register often with high win/loss ratios works as well. Just remember that you need to be flexible and
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    prepared to let go of old ideas that no longer work - and keep finding new ones that do. I think even the Boston Commodity Broker from Hell would agree with that. I know M
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    x would.

    Good Trading!

    There is substantial risk of loss trading futures and options and may not be suitable for all types of investors. Only risk capital should be used


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.suggest.org.ua/article/116742/suggest-Commodity-Trading-Blunders-IV-PART-4---My-Early-Days-As-A-Novice-Trader.html">Commodity Trading Blunders IV, PART 4 - My Early Days As A Novice Trader</a>

    BB link (for phorums):
    [url=http://www.suggest.org.ua/article/116742/suggest-Commodity-Trading-Blunders-IV-PART-4---My-Early-Days-As-A-Novice-Trader.html]Commodity Trading Blunders IV, PART 4 - My Early Days As A Novice Trader[/url]

    Related Articles:

    Step Up and Lead

    Analyzing Website Traffic Part 1

    Graphic Artist

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com

    Search Exchange Web Portal SpyderMap